About
Basic Data Updated:
4 months agoAjanta Pharma Ltd is known for its involvement in the development, manufacturing, and marketing of pharmaceutical formulations for both domestic and international markets. The company has a diverse product portfolio that covers various therapeutic segments, including anti-malarial, cardiovascular diseases (CVD), dermatology, ENT, gastroenterology, and ophthalmology. APL's manufacturing operations are spread across six plants, with five located in India and one in Mauritius. Additionally, APL has a dedicated Research and Development (R&D) center called 'Advent' in Mumbai. As of March 2017, the company has over 1,400 approved product registrations and an equal number of product registrations awaiting approvals.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | L24230MH1979PLC022059 |
| Company No. | 022059 |
| Stock Symbol | BSE : 532331 NSE : AJANTPHARM |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 31 Dec 1979 |
| Date of AGM | 18 Jul 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Listed |
| ROC Code | Roc Mumbai |
Products or Services related to Ajanta Pharma Limited
Bath Essentials
Mother Care
Facewash
Hair Growth for Men
Financials of Ajanta Pharma Limited
Enhance accessibility to Ajanta Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Ajanta Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Ajanta Pharma Limited
Unlock and access historical data on people associated with Ajanta Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
GS
Gaurang Shah
Company SecretaryAppointment Date: 08-Jan-2014
Status: Current
AA
Arvind Agrawal CFOAppointment Date: 30-Oct-2015
Status: Current
YA
Yogesh Agrawal Managing DirectorAppointment Date: 29-Apr-2000
Status: Current
Board Members(7)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Feb 2021 | ₹10.00 Cr | Open |
Citi Bank N.A. Creation Date: 26 Jun 2020 | ₹35.00 Cr | Open |
Others Creation Date: 03 Jul 1997 | ₹10.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ajanta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajanta Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
6 years 3 months 
Recent activity within the organization
Annual General Meeting
Ajanta Pharma Limited last Annual general meeting of members was held on 18 Jul 2023 as per latest MCA records.
18 Jul 2023Balance Sheet
Ajanta Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Charges
A charge registered on 15 Nov 2006 via Charge ID 10042802 with Idbi Bank Limited was fully satisfied on 24 Mar 2021.
24 Mar 2021Charges
A charge with Others of Rs. 10.00 cr registered on 03 Jul 1997 with Charge ID 80026318 was modified on 16 Mar 2021.
16 Mar 2021Charges
A charge registered on 08 Jul 1997 via Charge ID 90240349 with State Bank Of India was fully satisfied on 09 Mar 2021.
09 Mar 2021
Recent News, Updates & Announcement
Ajanta Pharma Q3 net profit jumps 56 YoY to Rs 210 crore revenue up 14.Moneycontrol 31 Jan 2024
- Ajanta gets US FDA approval for Topiramate ER Capsules.
Expresspharma 30 Aug 2023
- Ajanta Pharma Standalone June 2023 Net Sales at Rs 101458 crore up 1932 YoY.
Moneycontrol 29 Jul 2023
- Ajanta Pharma rises 1 on USFDA final nod for Clonidine Hydrochloride tablets.
Moneycontrol 22 Nov 2017
- Ajanta Pharma gets USFDA final nod for Clonidine Hydrochloride tablets.
4-Traders 21 Nov 2017
Frequently asked questions
What is the Incorporation or founding date of Ajanta Pharma Limited?
